MET and cancer: In confirmation of the functional consequences of bevacizumab-induced increased c-Met/β1 complex formation and increased cancer pathway gene expression, we found that bevacizumab increased intravasation of MDA-MB-231 cells (P < 0.001; Figure 2F and Supplemental Figure 8).